Concepedia
Statistics
Publications
43
Citations
2.6K
H-Index
27
Active since
1987
Affiliations
Bristol-Myers Squibb (United States)(Current)
Bristol-Myers Squibb (Germany)
Christchurch Hospital
Merck & Co., Inc., Rahway, NJ, USA (United States)
University of Washington
Gary C. Starling is an author at Bristol-Myers Squibb (United States) specializing in life sciences, immunology, and cell biology.
Publications per year
1987–2023
Elotuzumab directly enhances NK cell cytotoxicity against myeloma via CS1 ligation: evidence for augmented NK cell function complementing ADCC
Shauna M. Collins, Courtney E. Bakan, Gina D. Swartzel et al. · Cancer Immunology Immunotherapy · 2013 · 293 citations
Life Sciences, Immunology, Oncology +11
Differential Induction of Apoptosis by Fas–Fas Ligand Interactions in Human Monocytes and Macrophages
Peter A. Kiener, Patricia M. Davis, Gary C. Starling et al. · The Journal of Experimental Medicine · 1997 · 248 citations · Full text
Life Sciences, Cell Biology, Immunology +17
Human monocytic cells contain high levels of intracellular Fas ligand: rapid release following cellular activation
Peter A. Kiener, Patricia M. Davis, Bruce Rankin et al. · The Journal of Immunology · 1997 · 204 citations · Full text
Life Sciences, Cell Biology, Immunology +12
Elotuzumab enhances natural killer cell activation and myeloma cell killing through interleukin-2 and TNF-α pathways
Balaji Balasa, Rui Yun, Nicole A. Belmar et al. · Cancer Immunology Immunotherapy · 2014 · 154 citations · Full text
Medicine, Immunology, Pharmacology +17
Activation of human peripheral blood dendritic cells induces the CD86 co‐stimulatory molecule
Alexander D. McLellan, Gary C. Starling, Lisa A. Williams et al. · European Journal of Immunology · 1995 · 136 citations
1–5 of 43